VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis

Zhaoxin Hu, Hao Zhang, Bin Yi, +6

Cell Death and Disease

SIRT1 Regulates N6‐Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2‐Dependent FTO SUMOylation

Xiaoming Liu, Jianye Liu, Wen Xiao, +19

Hepatology

WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis

Panpan Tai, Xinyu Chen, Guihua Jia, +26

Journal of Translational Medicine

Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer

Xingyu Chen, Haotian Chen, Honghui Yao, +8

Oncogene

UrologyTumor Immune MicroenvironmentNon-immunoreactive TumorsGenitourinary CancerCancer Immunosurveillance +8

SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival

Jia‐Lin Liu, Qing-hai Zeng, Peiguo Cao, +17

Oncogene

UrologyPoorer SurvivalGenitourinary CancerMedicineApoptosis +7

RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway

Jian-Ye Liu, Qing-hai Zeng, Peiguo Cao, +16

British Journal of Cancer

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma

Yi Jin, Zhanwang Wang, Dong He, +7

Frontiers in Immunology

EngineeringImmunologyPathologyImmunotherapyGene Expression Profiling +16

Identification of novel subtypes based on ssGSEA in immune‐related prognostic signature for tongue squamous cell carcinoma

Yi Jin, Zhanwang Wang, Dong He, +3

Cancer Medicine

Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy

Qinghai Zeng, Jianye Liu, Peiguo Cao, +16

Clinical Cancer Research

CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer

Xingyu Chen, Runshi Xu, Dong He, +11

Oncogene

Cd8+ T EffectorUrologyImmune Checkpoint SignaturesCancer ImmunosurveillanceGenitourinary Cancer +7